| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |